Xolair 150 MG/1.2 ML powder VLS
Ended Awarded
- Contract number
- SPE2DB25FZG27
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,422
Award facts
- Contract value 100% obligated
- $46,422.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $46,422.00 by the Defense Logistics Agency on August 15, 2025, for the supply of Xolair 150 mg/1.2 ml powder vials. The contract utilizes a firm fixed-price arrangement with an ultimate completion date of September 8, 2025, and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue firm fixed-price delivery orders for pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group serves as a critical supplier in the federal pharmaceutical supply chain, specializing in providing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare systems. The company's extensive contract portfolio with the DLA demonstrates its capability to distribute a diverse range of pharmaceutical products, from specialty medications to vaccines and injections. Xolair, a biologic medication used in respiratory and allergic disease treatment, represents the type of specialized pharmaceutical inventory maintained through the company's distribution network to support military medical facilities.
Quick answers
Who was awarded contract SPE2DB25FZG27?
SPE2DB25FZG27 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 15, 2025.
How much is contract SPE2DB25FZG27 worth?
The government has obligated $46,422 on SPE2DB25FZG27.
Is contract SPE2DB25FZG27 an order under another contract?
Yes. SPE2DB25FZG27 is a delivery order under SPE2DB22D9205, an indefinite delivery contract.
Was contract SPE2DB25FZG27 competed?
The extent of competition for SPE2DB25FZG27 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award